Peroxiredoxin-4 and beta-hydroxybutyrate after SGLT2 inhibitor treatment in heart failure with preserved ejection fraction
19 May 2025 (09:00 - 09:45)
Organised by: 
About the speaker
Cardiovascular Research Institute Maastricht (CARIM), Maastricht (Netherlands (The))
3 More presentations in this session
Associate Professor A. Briasoulis (Athens, GR)
Assistant Professor M. Pandrc (Belgrade, RS)
Access the full session
The Event
Heart Failure 2025
19 May 2025
09:00 CET
You may be interested in
Congress Session
Congress Session
